We performed total enterolysis in 130 patients with encapsulating peritoneal sclerosis (EPS) between 1993 and 2007. The postoperative survival rate was 93.1%. However, 33 of the patients (25.4%) required additional surgery for recurrent bowel obstruction. To prevent recurrent bowel obstruction, we investigated various techniques following total enterolysis. In 7 patients, we employed the splint...

BACKGROUND Encapsulating Peritoneal Sclerosis (EPS) describes a variety of diseases that are frequently confused with different names and different etiopathogeneses. The aim of this article is to report personal experience of focusing on correct classification and the status of current diagnosis and treatment. METHODS A retrospective analysis was performed. Age, sex, ethnic origin, past medic...

Abstract Aims Encapsulating peritoneal sclerosis (EPS) is a rare phenomenon characterised by encasement and obstruction of the bowel thickened peritoneum. In our centre, EPS laparotomies are typically managed with open abdomen (OA) planned relook at 24-48 hours. The aim study was to compare ABTHERATM negative pressure wound therapy (NPWT) packing (betadine-soaked gauze) as temporary abdominal c...

Long-term continuous ambulatory peritoneal dialysis (CAPD) often causes peritoneal fibrosis and sclerosis with a loss of function, and some CAPD patients develop sclerosing encapsulating peritonitis. Glucose-based peritoneal dialysis fluids readily produce glucose degradation products by heat sterilization, and glucose degradation products accelerate the formation of advanced glycation end-prod...

Encapsulating peritoneal sclerosis (EPS) is a major and fatal complication of peritoneal dialysis (PD). For treatment, the efficacies of steroids, tamoxifen, immunosuppressants, and surgical total intestinal enterolysis have been reported, but the results have not been sufficient. Because treatment after the onset of EPS is limited, a prophylactic therapy is needed. We previously reported that ...

Abstract Background and Aims Encapsulating peritoneal sclerosis (EPS) is a life-threatening complication of long-term dialysis (PD). Causative factors are the chronic exposure to bioincompatible PD peritonitis episodes. Pro-inflammatory state oxidative stress associated with uremia may further accelerate these pathomechanisms. Clinical symptoms are, essentially, signs intestinal obstruction. Tr...